Gordon Bates News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Jason visa c. E. O. Al kelly, no relation, says consumers are still swiping and tapping despite talk of a recession. Carol and then theres this weeks cover story. Google and the generals. The search giant wants to build its military business, its employees they do not. Jason much more of that ahead but we begin with our top stories. A busy week in d. C. With impeachment hearings. Trade talks hitting a series of road bumps. So much more and legislation passed by congress, supporting hong kong protesters. Lets break it down with Ryan Teague Beckwith in d. C. So ryan, help us understand everythin...

The search giant wants to build its military business, its employees they do not. Jason much more of that ahead but we begin with our top stories. A busy week in d. C. With impeachment hearings. Trade talks hitting a series of road bumps. So much more and legislation passed by congress, supporting hong kong protesters. Lets break it down with Ryan Teague Beckwith in d. C. So ryan, help us understand everything that happened there in the nations capital. Ryan yeah. This was a long week. And i think the last news day was june 15, 2015. [laughter] this was a particularly newsy week. The sondland ...

Lonza Group AG: Lonza Announces Construction of a New Small Molecule Manufacturing Complex in Visp Lonza will invest CHF 200 million to construct a new manufacturing complex The 2000 m2 complex will include a customer dedicated manufacturing line for antibody-drug conjugate payload molecules The investment is supported by a long-term collaboration and capital contribution with a major biopharmaceutical partner The new manufacturing complex is designed to accommodate future small molecule expansions Quote from Maurits Janssen, Strategic Business Development Small Molecules, Lonza: "Supply is c...

Lonza divests two sites in France and Scotland By Mary Page Bailey | April 1, 2021 Lonza AG (Basel, Switzerland) has completed the sale of its sites in Ploermel, France and Edinburgh, Scotland to Next Pharma. Gordon Bates, President and Head of Small Molecules, Lonza said: “The strategic divestment of our Ploermel and Edinburgh sites will enable NextPharma to benefit from operational synergies and optimize existing expertise and technologies. In this context, as we close the divestment process, we are confident that NextPharma is well placed to develop and grow both sites to their full pot...

Lonza is to sell off two European sites to NextPharma in a deal that gives the contract development and manufacturing firm facilities to work with lipid oral dosage forms for the nutrition and pharma markets. The production sites in Ploermel in France and Edinburgh in the UK, employs around 260 and 130 permanent staff respectively and produces liquid-filled hard capsules (including Licaps) and softgels (including for high potent and hormonal products). “NextPharma is an established and well-respected company, with extensive experience in oral and topical finished...